BPA Call W81K0222A0010-HT009024FG0670039
Award Date 6/5/24
Potential Completion Date 9/30/24
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bassett, CA 91746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products. The contract is for the provision of breastmilk fortification products for use with extremely premature infants in neonatal intensive care units. The total ceiling value of the contract is $74,175.11, with a period of performance through September 30, 2024. Prolacta Bioscience holds...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products. The $44,965.41 contract is for the purchase of breastmilk fortification products for extremely low birth weight and premature infants in the neonatal intensive care unit. This BPA call contract is one of several indefinite delivery vehicles Prolacta Bioscience holds with the DHA,...
- The Defense Health Agency awarded a $24,971.50 firm fixed price Blanket Purchase Agreement (BPA) call contract to Prolacta Bioscience, Inc. on November 10, 2025, for the purchase of Prolacta breastmilk products and related nutritional supplements for premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract carries no set-aside designation and is scheduled for completion by September 30, 2026. Prolacta Bioscience, a for-profit manufacturer based in City...
- This is a federal contract award to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products for premature and critically ill infants. The contract, valued at $24,533.58, is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a component of the Department of Defense. The contract is for the provision of Prolacta's donor breastmilk products to be used in Neonatal Intensive Care Units (NICUs) at military medical facilities. This is not...
- The Defense Health Agency awarded a $24,246.50 firm fixed price Blanket Purchase Agreement (BPA) call contract to Prolacta Bioscience, Inc. on July 28, 2025, with completion scheduled for September 30, 2025. This task order is for the provision of Prolacta breastmilk products specifically designed for administration to critically ill and premature infants in neonatal intensive care units (NICUs). The contract carries no set-aside designation and will be performed at the contractor's facility...
- This contract was awarded to Prolacta Bioscience, Inc. by the Department of the Army Medical Command. The contract, valued at $150,000.00, is for the provision of human milk-based neonatal nutrition products to support premature and critically ill infants treated at military medical facilities. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and a performance period ending on September 30, 2022. Prolacta Bioscience, a manufacturer of goods, has...
- The Defense Health Agency awarded a $35,818.34 firm fixed price call under an existing Blanket Purchase Agreement to Prolacta Bioscience, Inc. for the purchase of human milk-based nutritional products to support premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract, which commenced on October 1, 2025, and extends through September 30, 2026, requires no set-aside designation. Prolacta Bioscience, headquartered in City of Industry, California,...
- This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide Prolacta's proprietary human milk-based nutritional products for use with infants in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The $15,536.12 contract is a call against a larger $250,000 single-award blanket purchase agreement for donor human milk and a $1.75 million single-award BPA for various human milk-based products to support military treatment...
- Prolacta Bioscience, Inc., a manufacturer of human milk-based neonatal nutrition products, was awarded a $147,221.00 firm fixed price purchase order from the Defense Health Agency. The contract is for the delivery of PROLAC BOTTLES with a completion date of January 13, 2021. This award is not associated with any set-aside designation. Prolacta Bioscience provides specialized nutritional support for premature and critically ill infants treated at military medical facilities, including locations...
- This federal contract award to Prolacta Bioscience, Inc. is for PROLACT+6 HMF and PROLACTA NEONATAL FORMULA products. The $3,254,150.28 fixed-price contract was awarded on October 1, 2019 by the Defense Health Agency, a defense agency, and has an ultimate completion date of September 30, 2024. The contract does not have a set-aside designation. Prolacta Bioscience, a for-profit manufacturer of human milk-based nutritional products, is the prime contractor. The award is associated with three...